
zzso to normal zzso remains the most important limiting factor in the treatment of cancer by zzso In order to deliver a radiation dose sufficient to eradicate a zzso zzso the normal zzso need to be zzso A number of pharmacological agents have been used zzso and some zzso to alleviate radiation damage to normal zzso but at present there is no effective clinical treatment to protect normal zzso against radiation zzso This paper reviews the efficacy of pharmacological substances used after radiation zzso The limited evidence available suggests that radiation zzso like many other tissue injuries, is amenable to pharmacological zzso However, care must be taken in the administration of these substances for the management of different aspects of radiation damage because there appears to be a zzso response to different pharmacological zzso Also, one must be aware of the limitations of results obtained from animal models, which do not necessarily correlate to benefits in the zzso the conflicting results reported with some zzso of radiation zzso and the toxicity of these substances and radiation doses used in published zzso zzso results may arise from differences in the zzso processes involved in the development of radiation zzso in different zzso and in the markers used to assess the efficacy of treatment zzso 

